Page last updated: 2024-09-05

sorafenib and Overweight

sorafenib has been researched along with Overweight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Du, XY; Feng, NN; Jiao, ZK; Wu, XH; Yang, BM; Zhang, YS	1

Other Studies

1 other study(ies) available for sorafenib and Overweight

Article	Year
Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma. Frontiers in endocrinology, 2022, Volume: 13 Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclic Nucleotide Phosphodiesterases, Type 6; Eye Proteins; Humans; Liver Neoplasms; Obesity; Overweight; Retrospective Studies; Serine Endopeptidases; Sorafenib; Transcriptome; Tumor Microenvironment	2022

Article

Year

Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.

Frontiers in endocrinology, 2022, Volume: 13

Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclic Nucleotide Phosphodiesterases, Type 6; Eye Proteins; Humans; Liver Neoplasms; Obesity; Overweight; Retrospective Studies; Serine Endopeptidases; Sorafenib; Transcriptome; Tumor Microenvironment

2022